Sort
15,440 grants matching “organoids”
Developmental programming of adult stem cells
$2,970,076Miyeko Mana · Arizona State University-Tempe Campus · R01 · FY2025 · DK
Somatic Truncation Mutations of the Histone Methyltransferase MLL4 Alter Its Subcellular Localization in Bladder Cancer: Mechanistic Insight and Targeted Therapeutic Approach
$2,970,010Ali Shilatifard · Northwestern University At Chicago · R01 · FY2025 · CA
Targeting Replication Stress and DNA Damage Response in Uterine Cancer
$2,955,234Ursula Anne Matulonis · Dana-Farber Cancer Inst · P01 · FY2025 · CA
Overcoming mechanisms of therapeutic resistance in pancreatic ductal adenocarcinoma
$2,953,179Tony R. Hunter · Salk Institute For Biological Studies · P01 · FY2023 · CA
Developing Pluripotent Stem Cells to Model and Treat Lung Disease
$2,941,211Darrell N. Kotton · Boston University Medical Campus · P01 · FY2024 · HL
Scaled identification of receptor-targeted AAVs for potent and cell type-specific transgene delivery
$2,935,208Viviana Gradinaru · California Institute Of Technology · U01 · FY2025 · MH
Overcoming mechanisms of therapeutic resistance in pancreatic ductal adenocarcinoma
$2,922,916Tony R. Hunter · Salk Institute For Biological Studies · P01 · FY2024 · CA
Project 4 - Inhibitors of Flavivirus Replication
$2,911,345Margo A Brinton · Emory University · U19 · FY2022 · AI
CHARACTERIZING AND IMPROVING HUMANIZED IMMUNE SYSTEM MOUSE MODELS (IMM-HIS)
$2,907,745J Victor Garcia-Martinez · Univ Of North Carolina Chapel Hill · N01 · FY2020 · AI
Overcoming mechanisms of therapeutic resistance in pancreatic ductal adenocarcinoma
$2,905,942Tony R. Hunter · Salk Institute For Biological Studies · P01 · FY2025 · CA
Environmental Signaling in Reproduction and Pregnancy
$2,903,223Francesco Demayo · National Institute Of Environmental Health Sciences · ZIA · FY2025 · ES
MTM 2: Combining structural informatics and crosslinking mass spectrometry to predict the key protein-protein interactions shaping symbiotic microbial communities
$2,899,960Lydia Freddolino · Regents Of The University Of Michigan - Ann Arbor · · FY2020 · BIO
Center for Personal Dynamic Regulomes
$2,898,972Howard Y Chang · Stanford University · RM1 · FY2019 · HG
Development of selective and potent protease inhibitors for corona and other pandemic viruses
$2,897,311Michael Z. Lin · Stanford University · U19 · FY2022 · AI
DNA Sequencing and FACS Core Facilities
$2,894,589Paul Robbins · Division Of Basic Sciences - Nci · ZIC · FY2023 · CA
Cellular senescence and cell fate/interactions as drivers of Alzheimer's and age-related dementias
$2,890,235Judith Campisi · Buck Institute For Research On Aging · P01 · FY2021 · AG
Cellular senescence and cell fate/interactions as drivers of Alzheimer's and age-related dementias
$2,884,435Judith Campisi · Buck Institute For Research On Aging · P01 · FY2022 · AG
Targeting Transcription and Splicing in Cancer
$2,880,000Christopher Vakoc · Cold Spring Harbor Laboratory · P01 · FY2023 · CA
Targeting Transcription and Splicing in Cancer
$2,880,000Christopher Vakoc · Cold Spring Harbor Laboratory · P01 · FY2025 · CA
Cellular senescence and cell fate/interactions as drivers of Alzheimer's and age-related dementias
$2,878,430Lisa M. Ellerby · Buck Institute For Research On Aging · P01 · FY2023 · AG
Cellular senescence and cell fate/interactions as drivers of Alzheimer's and age-related dementias
$2,872,219Lisa M. Ellerby · Buck Institute For Research On Aging · P01 · FY2024 · AG
Understanding and Harnessing Microbial Reprogramming to Combat Carcinogenic Colibactin in Colorectal Cancer
$2,864,671Jiahe Li · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Drug Repurposing Screening for Rare and Neglected Diseases
$2,859,284Wei Zheng · National Center For Advancing Translational Sciences · ZIA · FY2023 · TR
Disease Mechanisms of Early Pulmonary Fibrosis
$2,857,933Timothy S Blackwell · University Of Michigan At Ann Arbor · P01 · FY2024 · HL
Developing Pluripotent Stem Cells to Model and Treat Lung Disease
$2,850,680Darrell N. Kotton · Boston University Medical Campus · P01 · FY2025 · HL